Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age Related Macular Degeneration”

366 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 366 results

Not applicableStudy completedNCT01914380
What this trial is testing

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 988
Large-scale testing (Phase 3)Study completedNCT03668054
What this trial is testing

Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)

Who this might be right for
Age-Related Macular Degeneration
Laboratorio Elea Phoenix S.A. 22
Early research (Phase 1)Ended earlyNCT04594681
What this trial is testing

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Healthy VolunteersWet Age-related Macular Degeneration
Kyowa Kirin Co., Ltd. 116
Testing effectiveness (Phase 2)Study completedNCT00259753
What this trial is testing

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
OPKO Health, Inc. 120
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Study completedNCT02157077
What this trial is testing

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Macular DegenerationWet Macular DegenerationRetinal Degeneration+2 more
Centre Hospitalier Intercommunal Creteil 90
Large-scale testing (Phase 3)Ended earlyNCT04757636
What this trial is testing

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 998
Not applicableStudy completedNCT01473251
What this trial is testing

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Who this might be right for
Exudative Macular DegenerationDiabetic Macular Edema
Vitreo-Retinal Associates, Michigan 16
Early research (Phase 1)Study completedNCT01941082
What this trial is testing

RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Study completedNCT04200248
What this trial is testing

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 94
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Not applicableStudy completedNCT03438669
What this trial is testing

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients

Who this might be right for
Macular Degeneration
Dr. med. Katja Hatz 53
Testing effectiveness (Phase 2)Looking for participantsNCT07185841
What this trial is testing

Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (AMD)
Fujian Haixi Pharmaceuticals Co., Ltd. 198
Testing effectiveness (Phase 2)Looking for participantsNCT04504123
What this trial is testing

MMP-9 Inhibition for Recalcitrant Wet AMD

Who this might be right for
Exudative Macular DegenerationWet Age-related Macular Degeneration
University of Iowa 50
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Early research (Phase 1)Study completedNCT04884399
What this trial is testing

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Who this might be right for
Wet Age-related Macular Degeneration
Shanghai Biomabs Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Not applicableStudy completedNCT01404845
What this trial is testing

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Who this might be right for
Exudative Age-related Macular Degeneration
Affordance 200
Post-approval studies (Phase 4)Study completedNCT02441816
What this trial is testing

VITAL - Individualising Therapy for Neovascular AMD With Aflibercept

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 50
Not applicableUnknownNCT02747368
What this trial is testing

Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Turku University Hospital 600
Load More Results